Obesity care, GLP-1s and the new equation for plan sponsors GLP-1s are transforming obesity care, and the decisions plan sponsors make will impact their organizations for years to come Daniel Cusator , MD, MBA, Account Medical Director, Blue Cross Blue Shield of Tennessee Shane Lipp , Senior Benefits Manager, Synovus Claire Morrow , PT, DPT, OCS, FAAOMPT, Physical Therapy Consultant Senior Manager, Hinge Health Charlie Smith , MD, Chief Medical Officer, AON Gabrielle Boisvert , Head of Solution Strategy, Teladoc Health (Moderator) In 2021, it was the beginning of the widespread, mainstream use of GLP-1s for weight loss
Unfortunately there is no reliable way to measure how accurate the C rating actually is unless you go and fly the lipo and see how well it performs
"Iron Deficiency Anaemia in pregnancy and after birth"
Sarcopenia: revised European consensus on definition and diagnosis